2022

Eloy P, Laouénan C, Beavogui AH, Keita S, Manchon P, Etard JF, Sissoko D, Mentré F, Malvy D
High doses of favipiravir in two men survivors of Ebola virus disease carrying Ebola virus in semen in Guinea.
IDCases 2022, 27, e01412.

David C, Duployez N, Eloy P, Belhadi D, Chezel J, Guern VL, Laouénan C, Fenwarth L, Rouzaud D, Mathian A, de Almeida Chaves S, Duhaut P, Fain O, Galicier L, Ghillani-Dalbin P, Kahn JE, Morel N, Perard L, Pha M, Sarrot-Reynauld F, Aumaitre O, Chasset F, Limal N, Desmurs-Clavel H, Ackermann F, Amoura Z, Papo T, Preudhomme C, Costedoat-Chalumeau N, Sacre K
Clonal haematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study).
Rheumatology (Oxford, England) 2022, 61, 4355-4363.

Bretagne S, Sitbon K, Desnos-Ollivier M, Garcia-Hermoso D, Letscher-Bru V, Cassaing S, Millon L, Morio F, Gangneux JP, Hasseine L, Favennec L, Cateau E, Bailly E, Moniot M, Bonhomme J, Desbois-Nogard N, Chouaki T, Paugam A, Bouteille B, Pihet M, Dalle F, Eloy O, Sasso M, Demar M, Mariani-Kurkdjian P, Robert V, Lortholary O, Dromer F, FMSG
Active Surveillance Program to Increase Awareness on Invasive Fungal Diseases: the French RESSIF Network (2012 to 2018).
mBio 2022, 13, e0092022.

2021

Eloy P, Le Grand R, Malvy D, Guedj J
Combined treatment of molnupiravir and favipiravir against SARS-CoV-2 infection: One + zero equals two?.
EBioMedicine 2021, 74, 103663.

Eloy P, Tardivon C, Martin-Blondel G, Isnard M, Turnier PL, Marechal ML, Cabié A, Launay O, Tattevin P, Senneville E, Ansart S, Goehringer F, Chirouze C, Bousson L, Laouénan C, Etienne M, Nguyen D, Ghosn J, Duval X, FCcsaig
Severity of self-reported symptoms and psychological burden 6-months after hospital admission for COVID-19: a prospective cohort study.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2021, 112, 247-253.

Gonthier MC, Gendron N, Eloy P, Bourrienne MC, Alhenc-Gelas M, Pouplard C, Tardy B, Szymezak J, Burdet C, Gkalea V, Faille D, Ajzenberg N
Heparin-induced Thrombocytopenia Diagnosis: A Retrospective Study Comparing Heparin-induced Platelet Activation Test to 14 C-serotonin Release Assay.
TH open: companion journal to thrombosis and haemostasis 2021, 5, e507-e512.

Montravers P, Esposito-Farèse M, Lasocki S, Grall N, Veber B, Eloy P, Seguin P, Weiss E, Dupont H
Risk factors for therapeutic failure in the management of post-operative peritonitis: a post hoc analysis of the DURAPOP trial.
The Journal of Antimicrobial Chemotherapy 2021, dkab307.

2020

Eloy P, Solas C, Touret F, Mentré F, Malvy D, de Lamballerie X, Guedj J
Dose rationale for favipiravir use in patients infected with SARS-CoV-2.
Clinical Pharmacology and Therapeutics 2020

2017

Eloy P, Tessier A, Fan-Havard P, Chou M, Verstuyft C, Taburet AM, Haas DW, Bertrand J, ASG
Genetics of Nevirapine Metabolic Pathways at Steady State in HIV-Infected Cambodians.
Antimicrobial Agents and Chemotherapy 2017, 61, e00733-17.

2015

Lecefel C, Eloy P, Chauvin B, Wyplosz B, Amilien V, Massias L, Taburet AM, Francois H, Furlan V
Worsening pneumonitis due to a pharmacokinetic drug-drug interaction between everolimus and voriconazole in a renal transplant patient.
Journal of Clinical Pharmacy and Therapeutics 2015, 40, 119-120.

2014

Liapis E, Pantel A, Robert J, Nicolas-Chanoine MH, Cavalié L, van der Mee-Marquet N, de Champs C, Aissa N, Eloy C, Blanc V, Guyeux C, Hocquet D, Lavigne JP, Bertrand X, O
Molecular epidemiology of OXA-48-producing Klebsiella pneumoniae in France.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, O1121-1123.

2013

Gharbi M, Flegg JA, Hubert V, Kendjo E, Metcalf JE, Bertaux L, Guérin PJ, Le Bras J, MotFNRCfIMS, Aboubaca A, Agnamey P, Angoulvant A, Barbut P, Basset D, Belkadi G, Bellanger AP, Bemba D, Benoit-Vica F, Berry A, Bigel ML, Bonhomme J, Botterel F, Bouchaud O, Bougnoux ME, Bourée P, Bourgeois N, Branger C, Bret L, Buret B, Casalino E, Chevrier S, Conquere de Monbrison F, Cuisenier B, Danis M, Darde ML, De Gentile L, Delarbre JM, Delaunay P, Delaval A, Desoubeaux G, Develoux M, Dunand J, Durand R, Eloy O, Fauchet N, Faugere B, Faye A, Fenneteau O, Flori P, Fontrouge M, Garabedian C, Gayandrieu F, Godineau N, Houzé P, Houzé S, Hurst JP, Ichou H, Lachaud L, Lebuisson A, Lefevre M, LeGuern AS, Le Moal G, Lusina D, Machouart MC, Malvy D, Matheron S, Maubon D, Mechali D, Megarbane B, Menard G, Millon L, Aiach MM, Minodier P, Morelle C, Nevez G, Parola P, Parzy D, Patey O, Patoz P, Penn P, Perignon A, Picot S, Pilo JE, Poilane I, Pons D, Poupart M, Pradines B, Raffenot D, Rapp C, Receveur MC, Sarfati C, Senghor Y, Simon F, Siriez JY, Taudon N, Thellier M, Thouvenin M, Toubas D
Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011.
Malar. J. 2013, 12, 35.